<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1149" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1149/" /><meta name="ncbi_pagename" content="Lesch-Nyhan Syndrome - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Lesch-Nyhan Syndrome - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Lesch-Nyhan Syndrome" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2014/05/15" /><meta name="citation_author" content="William L Nyhan" /><meta name="citation_author" content="J Patrick O'Neill" /><meta name="citation_author" content="Hyder A Jinnah" /><meta name="citation_author" content="James C Harris" /><meta name="citation_pmid" content="20301328" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1149/" /><meta name="citation_keywords" content="HGPRT Deficiency" /><meta name="citation_keywords" content="HPRT Deficiency" /><meta name="citation_keywords" content="Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency" /><meta name="citation_keywords" content="Lesch-Nyhan Disease" /><meta name="citation_keywords" content="HGPRT Deficiency" /><meta name="citation_keywords" content="HPRT Deficiency" /><meta name="citation_keywords" content="Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency" /><meta name="citation_keywords" content="Lesch-Nyhan Disease" /><meta name="citation_keywords" content="Hypoxanthine-guanine phosphoribosyltransferase" /><meta name="citation_keywords" content="HPRT1" /><meta name="citation_keywords" content="Lesch-Nyhan Syndrome" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Lesch-Nyhan Syndrome" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="William L Nyhan" /><meta name="DC.Contributor" content="J Patrick O'Neill" /><meta name="DC.Contributor" content="Hyder A Jinnah" /><meta name="DC.Contributor" content="James C Harris" /><meta name="DC.Date" content="2014/05/15" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1149/" /><meta name="description" content="Lesch-Nyhan syndrome is characterized by motor dysfunction that resembles cerebral palsy, cognitive and behavioral disturbances, and uric acid overproduction (hyperuricemia). The most common presenting features, hypotonia and developmental delay, are evident by age three to six months. Affected children are delayed in sitting and most never walk. Within the first few years, extrapyramidal involvement (e.g., dystonia, choreoathetosis, opisthotonos) and pyramidal involvement (e.g., spasticity, hyperreflexia, extensor plantar reflexes) become evident. Cognitive impairment and behavioral disturbances emerge between ages two and three years. Persistent self-injurious behavior (biting the fingers, hands, lips, and cheeks; banging the head or limbs) is a hallmark of the disease. Overproduction of uric acid may lead to deposition of uric acid crystals or calculi in the kidneys, ureters, or bladder. Gouty arthritis may occur later in the disease. Related disorders with less severe manifestations include hyperuricemia with neurologic dysfunction but no self-injurious behavior and hyperuricemia alone, sometimes with acute renal failure." /><meta name="og:title" content="Lesch-Nyhan Syndrome" /><meta name="og:type" content="book" /><meta name="og:description" content="Lesch-Nyhan syndrome is characterized by motor dysfunction that resembles cerebral palsy, cognitive and behavioral disturbances, and uric acid overproduction (hyperuricemia). The most common presenting features, hypotonia and developmental delay, are evident by age three to six months. Affected children are delayed in sitting and most never walk. Within the first few years, extrapyramidal involvement (e.g., dystonia, choreoathetosis, opisthotonos) and pyramidal involvement (e.g., spasticity, hyperreflexia, extensor plantar reflexes) become evident. Cognitive impairment and behavioral disturbances emerge between ages two and three years. Persistent self-injurious behavior (biting the fingers, hands, lips, and cheeks; banging the head or limbs) is a hallmark of the disease. Overproduction of uric acid may lead to deposition of uric acid crystals or calculi in the kidneys, ureters, or bladder. Gouty arthritis may occur later in the disease. Related disorders with less severe manifestations include hyperuricemia with neurologic dysfunction but no self-injurious behavior and hyperuricemia alone, sometimes with acute renal failure." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1149/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/lns/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1149/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BDEA9E04084E10000000007A602BA.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1149_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1149_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lenz/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/leukodys-ov/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1149_"><span class="title" itemprop="name">Lesch-Nyhan Syndrome</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: HGPRT Deficiency, HPRT Deficiency, Hypoxanthine-Guanine Phosphoribosyltransferase Deficiency, Lesch-Nyhan Disease</div><p class="contrib-group"><span itemprop="author">William L Nyhan</span>, MD, PhD, <span itemprop="author">J Patrick O'Neill</span>, PhD, <span itemprop="author">Hyder A Jinnah</span>, MD, PhD, and <span itemprop="author">James C Harris</span>, MD.</p><a data-jig="ncbitoggler" href="#__NBK1149_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1149_ai__"><div class="contrib half_rhythm"><span itemprop="author">William L Nyhan</span>, MD, PhD<div class="affiliation small">Professor, Department of Pediatrics<br />University of California, San Diego<br />La Jolla, California<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dscu@nahynw" class="oemail">ude.dscu@nahynw</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">J Patrick O'Neill</span>, PhD<div class="affiliation small">Research Professor, Department of Pediatrics<br />University of Vermont<br />Burlington, Vermont<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.mvu@llieno.kcirtap" class="oemail">ude.mvu@llieno.kcirtap</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Hyder A Jinnah</span>, MD, PhD<div class="affiliation small">Professor, Department of Neurology<br />Emory University<br />Atlanta, Georgia<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.yrome@hannijh" class="oemail">ude.yrome@hannijh</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">James C Harris</span>, MD<div class="affiliation small">Professor, Departments of Psychiatry and Behavioral Sciences and Pediatrics<br />Johns Hopkins University School of Medicine<br />Baltimore, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.imhj@dsirrahj" class="oemail">ude.imhj@dsirrahj</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 25, 2000</span>; Last Update: <span itemprop="dateModified">May 15, 2014</span>.</p><p><em>Estimated reading time: 21 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="lns.Summary" itemprop="description"><h2 id="_lns_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Lesch-Nyhan syndrome is characterized by motor dysfunction that resembles cerebral palsy, cognitive and behavioral disturbances, and uric acid overproduction (hyperuricemia). The most common presenting features, hypotonia and developmental delay, are evident by age three to six months. Affected children are delayed in sitting and most never walk. Within the first few years, extrapyramidal involvement (e.g., dystonia, choreoathetosis, opisthotonos) and pyramidal involvement (e.g., spasticity, hyperreflexia, extensor plantar reflexes) become evident. Cognitive impairment and behavioral disturbances emerge between ages two and three years. Persistent self-injurious behavior (biting the fingers, hands, lips, and cheeks; banging the head or limbs) is a hallmark of the disease. Overproduction of uric acid may lead to deposition of uric acid crystals or calculi in the kidneys, ureters, or bladder. Gouty arthritis may occur later in the disease. Related disorders with less severe manifestations include hyperuricemia with neurologic dysfunction but no self-injurious behavior and hyperuricemia alone, sometimes with acute renal failure.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>A urinary urate-to-creatinine ratio greater than 2.0, indicating uric acid overproduction (hyperuricemia), is a characteristic for children younger than age ten years who have Lesch-Nyhan syndrome. However, neither hyperuricuria nor hyperuricemia (serum uric acid concentration &#x0003e;8 mg/dL) is sensitive or specific enough for diagnosis. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) enzyme activity less than 1.5% of normal in cells from any tissue (e.g., blood, cultured fibroblasts, lymphoblasts) is diagnostic. <i>HPRT1</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with Lesch-Nyhan syndrome.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Control of overproduction of uric acid with allopurinol reduces the risk for nephrolithiasis, urate nephropathy, gouty arthritis, and tophi but has no effect on behavioral and neurologic symptoms; treatment of renal stones may require lithotripsy or surgery. Baclofen or benzodiazepines for spasticity; physical, behavioral, psychiatric, protective equipment to reduce complications from self-injury and other deleterious behaviors.</p><p><i>Prevention of secondary compliations:</i> Adjustment of the dose of allopurinol is required to minimize the complication of nephrolithiasis; virtually any reduction of hyperuricemia will prevent urate nephropathy.</p><p><i>Surveillance:</i> Monitoring for early signs of self-injury; medical history, plasma uric acid concentration, urinary oxypurine excretion to monitor for signs of renal stones.</p><p><i>Agents/circumstances to avoid:</i> Probenecid and other uricosuric drugs designed to reduce the serum concentration of uric acid; periods of relative dehydration, which may increase risk for renal stones or urate nephropathy with resulting oliguria/anuria.</p><p><i>Evaluation of relatives at risk:</i> Prenatal testing or testing of at-risk males immediately after birth enables prompt initiation of allopurinol therapy; establishing the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of at-risk female relatives through genetic testing may allow for early treatment that reduces their risk for gout in later years.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>Lesch-Nyhan syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> manner. The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will neither have the disease nor be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of the mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>. The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the carrier status of the mother. Carrier females have a 50% chance of transmitting the <i>HPRT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in each pregnancy. Sons who inherit the pathogenic variant will be affected; daughters who inherit the pathogenic variant are carriers. Thus, with each pregnancy, a carrier female has a 25% chance of having an affected male, a 25% chance of having a carrier female, and a 50% chance of having an unaffected male or female. Carrier testing for at-risk relatives and prenatal testing for pregnancies at increased risk are possible if the pathogenic variant in the family is known.</p></div></div><div id="lns.Diagnosis"><h2 id="_lns_Diagnosis_">Diagnosis</h2><div id="lns.Clinical_Diagnosis"><h3>Clinical Diagnosis</h3><p>The diagnosis of Lesch-Nyhan syndrome is suspected in males with developmental delay who manifest the characteristic neurologic, cognitive, and behavioral disturbances [<a class="bk_pop" href="#lns.REF.lesch.1964.561">Lesch &#x00026; Nyhan 1964</a>, <a class="bk_pop" href="#lns.REF.nyhan.2005">Nyhan et al 2005</a>].</p></div><div id="lns.PreliminaryTesting"><h3>PreliminaryTesting</h3><p>Lesch-Nyhan syndrome is caused by deficiency of the enzyme hypoxanthine-guanine phosphoribosyltransferase (HPRT), which catalyzes the conversion of hypoxanthine to inosine monophosphate (inosinic acid, IMP) and guanine to guanine monophosphate (guanylic acid, GMP) in the presence of phosphoribosylpyrophosphate [<a class="bk_pop" href="#lns.REF.seegmiller.1967.1682">Seegmiller et al 1967</a>].</p><p><b>The urate-to-creatinine ratio,</b> calculated from the concentration of uric acid and creatinine in the urine, provides a reliable measure of uric acid overproduction. A urate-to-creatinine ratio greater than 2.0 is characteristic for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males younger than age ten years, but is not considered diagnostic.</p><p><b>Twenty-four-hour urate excretion</b> of more than 20 mg/kg is characteristic but not diagnostic.</p><p>Note: Good results with 24-hour samples are difficult to obtain. Bacterial contamination and/or precipitation of urate during collection can influence the result.</p><p><b>Hyperuricemia</b> (serum uric acid concentration &#x0003e;8 mg/dL) is often present but not sensitive or specific enough for diagnostic purposes.</p></div><div id="lns.Diagnostic_Testing"><h3>Diagnostic Testing</h3><p><b>HPRT enzyme activity</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>In males.</b> HPRT enzyme activity less than 1.5% of normal in cells from any tissue (e.g., blood, cultured fibroblasts, lymphoblasts) establishes the diagnosis of Lesch-Nyhan syndrome.</div><div class="half_rhythm">The assay that is simplest and most readily available is performed on erythrocytes in anticoagulant or on dried blood spots on filter paper [<a class="bk_pop" href="#lns.REF.nyhan.2008.559">Nyhan 2008</a>].</div><div class="half_rhythm">Assay of intact cells from cultured fibroblasts may be necessary to distinguish <a href="#lns.Genetically_Related_Allelic_Disorder">genetically related HPRT variant disorders</a> from classic Lesch-Nyhan syndrome [<a class="bk_pop" href="#lns.REF.page.1981.203">Page et al 1981</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>In females.</b> Measurement of HPRT enzyme activity for <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> detection is technically demanding and not widely used [<a class="bk_pop" href="#lns.REF.puig.1998.950">Puig et al 1998</a>]. Measurement of HPRT enzyme activity on hair bulbs from women at risk has yielded a small number of both false positive and false negative results.</div></li></ul><p><b>Proliferation of peripheral blood T-lymphocytes</b></p><ul><li class="half_rhythm"><div><b>In males.</b> In the presence of the purine analog 6-thioguanine, proliferation of peripheral blood T-lymphocytes (if available) is confirmatory in most cases.</div></li><li class="half_rhythm"><div><b>In females.</b> If the <i>HPRT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> is not known in the family, <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> for at-risk females may be possible by measuring the frequency of HPRT-deficient lymphocytes by their selective growth in medium containing 6-thioguanine [<a class="bk_pop" href="#lns.REF.oneill.2004.51">O'Neill 2004</a>]. The frequency of HPRT-deficient lymphocytes in a carrier female is approximately 0.5-5.0 x 10<sup>-2</sup>, whereas that of a non-carrier female is approximately 1-20 x 10<sup>-6</sup>. If available, this elevated frequency of HPRT-deficient lymphocytes is usually diagnostic by itself.</div></li></ul><div id="lns.Molecular_Genetic_Testing"><h4>Molecular Genetic Testing</h4><p><b>Gene.</b>
<i>HPRT1</i> is the only <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> known to be associated with Lesch-Nyhan syndrome.</p><div id="lns.T.summary_of_molecular_genetic_testi" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Summary of Molecular Genetic Testing Used in Lesch-Nyhan Syndrome</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1149/table/lns.T.summary_of_molecular_genetic_testi/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lns.T.summary_of_molecular_genetic_testi_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_2" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_3" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant Detectable by Method</th></tr><tr><th headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_3" id="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Affected Males</th><th headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_3" id="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Carrier Females</th></tr></thead><tbody><tr><td headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>HPRT1</i></td><td headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>2</sup> / scanning for pathogenic variants</td><td headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;90%-95%&#x000a0;<sup>3,&#x000a0;4</sup></td><td headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">~80%&#x000a0;<sup>5</sup></td></tr><tr><td headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:top;">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">See footnote 7</td><td headers="hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_1_3 hd_h_lns.T.summary_of_molecular_genetic_testi_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">21%-24%&#x000a0;<sup>8</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="lns.TF.1.1"><p class="no_margin">See <a href="/books/NBK1149/#lns.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein. See <a href="#lns.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>2. </dt><dd><div id="lns.TF.1.2"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>3. </dt><dd><div id="lns.TF.1.3"><p class="no_margin">Lack of amplification by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> prior to <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> can suggest a putative (multi)<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> on the X <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> males; confirmation may require additional testing by <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>.</p></div></dd><dt>4. </dt><dd><div id="lns.TF.1.4"><p class="no_margin"><a class="bk_pop" href="#lns.REF.jinnah.2000.309">Jinnah et al [2000]</a>, <a class="bk_pop" href="#lns.REF.jinnah.2004.1153">Jinnah et al [2004]</a></p></div></dd><dt>5. </dt><dd><div id="lns.TF.1.5"><p class="no_margin">Sequence analysis of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA cannot detect <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of one or more exons or the entire <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> in a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> female.</p></div></dd><dt>6. </dt><dd><div id="lns.TF.1.6"><p class="no_margin">Testing that identifies <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications not detectable by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of the coding and flanking <a class="def" href="/books/n/gene/glossary/def-item/intronic/">intronic</a> regions of <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> DNA. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA) that includes this gene/<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> segment.</p></div></dd><dt>7. </dt><dd><div id="lns.TF.1.7"><p class="no_margin">Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing can be used to confirm a putative <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>/whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in males after failure to amplify by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> in the <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</p></div></dd><dt>8. </dt><dd><div id="lns.TF.1.8"><p class="no_margin">Large deletions in <i>HPRT1</i> cannot be detected in females by <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>; <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> test methods to detect <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions are required [<a class="bk_pop" href="#lns.REF.jinnah.2000.309">Jinnah et al 2000</a>, <a class="bk_pop" href="#lns.REF.bertelli.2004.767">Bertelli et al 2004</a>].</p></div></dd></dl></div></div></div></div></div><div id="lns.Testing_Strategy"><h3>Testing Strategy</h3><p><b>To confirm/establish the diagnosis in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>HPRT enzyme assay.</b> One strategy for the diagnosis of Lesch-Nyhan syndrome is performance of an HPRT enzyme assay, which is most readily accomplished using erythrocyte hemolysates.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Molecular genetic testing.</b> An alternative strategy to HPRT enzyme assay is <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> of <i>HPRT1</i>.</div><ul><li class="half_rhythm"><div>Sequence analysis should be performed first.</div></li><li class="half_rhythm"><div>Deletion/<a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> testing can be used to confirm a putative <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a>/whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in a male after failure to amplify by <a class="def" href="/books/n/gene/glossary/def-item/pcr/">PCR</a> in the <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>.</div></li></ul><div class="half_rhythm">Note: (1) Failure to detect a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>HPRT1</i> does not exclude the diagnosis of Lesch-Nyhan syndrome. (2) Detection of a pathogenic variant in <i>HPRT1</i> is of particular utility to family members with respect to <a class="def" href="/books/n/gene/glossary/def-item/carrier-testing/">carrier testing</a> and <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a>.</div></li></ul></div></div><div id="lns.Clinical_Characteristics"><h2 id="_lns_Clinical_Characteristics_">Clinical Characteristics</h2><div id="lns.Clinical_Description"><h3>Clinical Description</h3><p>Lesch-Nyhan syndrome is characterized by neurologic dysfunction, cognitive and behavioral disturbances, and uric acid overproduction.</p><p><b>Neurologic dysfunction.</b> Individuals with Lesch-Nyhan syndrome typically have a normal prenatal and perinatal course. The most common presenting feature is developmental delay during the first year of life, with hypotonia and delayed motor skills usually evident by age three to six months. Children with Lesch-Nyhan syndrome fail to reach normal milestones such as sitting, crawling, and walking.</p><p>Within the first few years of life, abnormal involuntary movements indicative of extrapyramidal involvement emerge. The characteristic feature is severe action dystonia [<a class="bk_pop" href="#lns.REF.jinnah.2006.1201">Jinnah et al 2006</a>]. Affected children develop dystonia, choreoathetosis, opisthotonos, and sometimes ballismus. They also develop signs of pyramidal involvement including spasticity, hyperreflexia, and extensor plantar reflexes. The neurologic picture closely resembles athetoid cerebral palsy. Many <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children are initially diagnosed as having cerebral palsy.</p><p>The motor disability is so severe that virtually all children with the classic Lesch-Nyhan syndrome never walk and are confined to a wheelchair.</p><p><b>Cognitive and behavioral disturbances.</b> Most <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are cognitively impaired, a feature that is difficult to assess because of the behavioral disturbances, motor deficits, and attentional problems [<a class="bk_pop" href="#lns.REF.schretlen.2001.805">Schretlen et al 2001</a>, <a class="bk_pop" href="#lns.REF.schretlen.2005.673">Schretlen et al 2005</a>].</p><p>Almost all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals eventually develop persistent self-injurious behavior, a hallmark of the disease [<a class="bk_pop" href="#lns.REF.schretlen.2005.673">Schretlen et al 2005</a>]. Self-injury most often involves biting of the fingers, hands, lips, and cheeks [<a class="bk_pop" href="#lns.REF.robey.2003.167">Robey et al 2003</a>]. Other individuals bang their heads or limbs against hard objects. Some children develop self-injurious behavior during the first year of life; most develop it between ages two and three years, and some not until much later.</p><p>Other compulsive behaviors may include aggressiveness, vomiting, spitting, and coprolalia.</p><p><b>Overproduction of uric acid.</b> The overproduction of uric acid is present at birth but may not be recognized by routine clinical laboratory testing methods. The serum uric acid concentration is usually (but not always) elevated, as the excess purines may be effectively excreted into the urine.</p><p>Overproduction of uric acid may lead to deposition of uric acid crystals, sodium urate, or calculi in the kidneys, ureters, or bladder. Crystals appear as an orange sandy material; calculi may be multiple tiny stones ("gravel") or discrete large stones that are difficult to pass. The stones may cause hematuria and increase the risk for urinary tract infections. Stones may be the presenting feature of the disease, but often go unrecognized for months or years.</p><p><b>Gouty arthritis.</b> Another potential consequence of untreated hyperuricemia is gouty arthritis caused by uric acid crystal deposition in articular cartilage. Gout is uncommon in children with Lesch-Nyhan syndrome and typically develops long after other symptoms present.</p><p><b>Other.</b> Growth and puberty are delayed.</p><p>End-stage renal disease (ESRD), which prior to the availability of allopurinol was the rule in this disease, is less common now but still occurs.</p><p>Affected males may have testicular atrophy.</p><p>A megaloblastic anemia unresponsive to vitamin supplements is common, but often resolves spontaneously.</p><p>EEG may show nonspecific changes of slowing or disorganization.</p><p>Both CT and MRI may show nonspecific changes of atrophy in the central nervous system with reduced cerebral volume and reduced caudate nucleus volume [<a class="bk_pop" href="#lns.REF.harris.1998.547">Harris et al 1998</a>].</p><p><b>Life expectancy.</b> If management of symptoms is effective, most individuals survive into the second or third decade of life. There may be slow progression of disease in adulthood.</p><p>Sudden death is increasingly being recognized [<a class="bk_pop" href="#lns.REF.neychev.2006.923">Neychev &#x00026; Jinnah 2006</a>]. Respiratory abnormalities have been implicated. Sudden death appears to be more common in older individuals, often with no discernable cause even on autopsy. Report of atlantoaxial subluxation in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child age nine years tends to confirm suspicion that some sudden deaths have resulted from forcible opisthotonos [<a class="bk_pop" href="#lns.REF.hou.2006.1500">Hou 2006</a>].</p><p><b>Lesch-Nyhan syndrome in females.</b> The seven reported females with Lesch-Nyhan syndrome have had nonrandom <a class="def" href="/books/n/gene/glossary/def-item/x-chromosome-inactivation/">X-chromosome inactivation</a> or skewed inactivation of the X chromosome with the normal <i>HPRT1</i> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> [<a class="bk_pop" href="#lns.REF.de_gregorio.2000.263">De Gregorio et al 2000</a>, <a class="bk_pop" href="#lns.REF.jinnah.2000.309">Jinnah et al 2000</a>]. Twinning may have led to discordant phenotypes of skewed X-chromosome inactivation in two monozygotic sisters [<a class="bk_pop" href="#lns.REF.de_gregorio.2005.70">De Gregorio et al 2005</a>]. In one girl [<a class="bk_pop" href="#lns.REF.rinat.2006.249">Rinat et al 2006</a>], there was nonrandom inactivation of one X chromosome, whereas the expression of the other X chromosome was blocked by a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> X-autosome <a class="def" href="/books/n/gene/glossary/def-item/translocation/">translocation</a> with a break point in the <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> of <i>HPRT1</i>.</p><p>Although female carriers are generally asymptomatic, they may have increased uric acid excretion [<a class="bk_pop" href="#lns.REF.puig.1998.950">Puig et al 1998</a>] and some may develop symptoms of hyperuricemia in later years.</p></div><div id="lns.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>Observed <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> reflect 544 pathogenic variants in <i>HPRT</i> [<a class="bk_pop" href="#lns.REF.fu.2014.1282">Fu et al 2014</a>]. The amount of residual HPRT enzyme activity is important for the phenotype [<a class="bk_pop" href="#lns.REF.jinnah.2000.309">Jinnah et al 2000</a>, <a class="bk_pop" href="#lns.REF.jinnah.2004.1153">Jinnah et al 2004</a>]. Pathogenic variants that completely disrupt HPRT enzyme function are associated with Lesch-Nyhan syndrome, whereas pathogenic variants that allow some residual HPRT enzyme function may be associated with the less severe phenotypes (see <a href="#lns.Genetically_Related_Allelic_Disorder">Genetically Related Disorders</a>). Most individuals with the same <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have the same phenotype, but there are a few exceptions in which the identical variant has occurred with discordant clinical features, but all were variant phenotypes [<a class="bk_pop" href="#lns.REF.fu.2014.1282">Fu et al 2014</a>]. Certain pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants that have been identified several times independently cause only <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyperuricemia.</p><p>Pathogenic <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants have been analyzed for effects on HPRT enzyme structure [<a class="bk_pop" href="#lns.REF.duan.2004.599">Duan et al 2004</a>].</p></div><div id="lns.Nomenclature"><h3>Nomenclature</h3><p>Lesch-Nyhan syndrome is characterized by movement disorder, cognitive deficits, and self-injurious behavior.</p></div><div id="lns.Prevalence"><h3>Prevalence</h3><p>The prevalence of Lesch-Nyhan syndrome is approximately 1:380,000.</p><p>It appears to occur in all populations that have been studied, and with relatively equal frequency.</p></div></div><div id="lns.Genetically_Related_Allelic_Disorder"><h2 id="_lns_Genetically_Related_Allelic_Disorder_">Genetically Related (Allelic) Disorders</h2><p>Less severe syndromes caused by variant HPRT enzyme deficiency are also recognized, although they are much less common than Lesch-Nyhan syndrome. <a class="bk_pop" href="#lns.REF.puig.2001.102">Puig et al [2001]</a> identified HPRT variants as comprising four groups including Lesch-Nyhan syndrome. The spectrum of variant HPRT deficiency has also been reported by <a class="bk_pop" href="#lns.REF.jinnah.2010.671">Jinnah et al [2010]</a>. Distinguishing HPRT variants is useful clinically to help with prognosis of an infant newly diagnosed with HPRT deficiency, although this may not always be possible. Awareness has been increased for atypical presentations in which the diagnosis may be challenging.</p><p><b><a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> hyperuricemia.</b> Pathogenic variants allowing at least 8% of HPRT enzyme activity are associated with X-linked hyperuricemia, with an increased risk for uric acid crystal deposition in the urinary system and gouty arthritis (previously referred to as Kelley-Seegmiller syndrome). Affected individuals have no neurologic or behavioral abnormalities. Those with HPRT-related hyperuricemia alone may have a normal life span if they can avoid renal complications, especially the nephropathy and renal failure that result from deposition of sodium urate in the renal parenchyma [<a class="bk_pop" href="#lns.REF.srivastava.2002.219">Srivastava et al 2002</a>]. ESRD may be a special risk for <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in whom neurologic or behavioral features do not lead to early recognition [<a class="bk_pop" href="#lns.REF.kassimatis.2005.447">Kassimatis et al 2005</a>].</p><p><b>Hyperuricemia with neurologic disability.</b> Uric acid overproduction with neurologic disability but without behavioral disturbances has also been reported.</p><ul><li class="half_rhythm"><div>The most severely <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals are neurologically indistinguishable from those with classic Lesch-Nyhan syndrome but do not exhibit self-injurious behavior, whereas others may have only minor clumsiness with fine motor skills or slightly indistinct speech patterns and cognitive deficits [<a class="bk_pop" href="#lns.REF.schretlen.2001.805">Schretlen et al 2001</a>].</div></li><li class="half_rhythm"><div>An additional <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> designated HPRT<sub>Salamanca</sub> consists of spasticity, dystonic gait, and mild intellectual disability [<a class="bk_pop" href="#lns.REF.page.1987.713">Page et al 1987</a>]. Affected individuals in this group are able to walk.</div></li></ul></div><div id="lns.Differential_Diagnosis"><h2 id="_lns_Differential_Diagnosis_">Differential Diagnosis</h2><p>When fully developed with the three clinical elements of uric acid overproduction, neurologic dysfunction, and cognitive and behavioral disturbances, the diagnosis of Lesch-Nyhan syndrome is made readily. The main diagnostic difficulties arise during early stages when all the features are not yet apparent, or in individuals who have partial deficiency of HPRT enzyme activity.</p><p>The index of suspicion is raised when developmental delay is associated with hyperuricemia. Alternatively, the diagnosis should be suspected when developmental delay is associated with nephrolithiasis or hematuria caused by uric acid stones.</p><p>Lesch-Nyhan syndrome is often first suspected when self-injurious behavior develops. However, self-injurious behaviors occur in other conditions, including nonspecific intellectual disability, autism, <a href="/books/n/gene/rett/">Rett syndrome</a>, <a href="/books/n/gene/cdls/">Cornelia de Lange syndrome</a>, Tourette syndrome, <a href="/books/n/gene/fd/">familial dysautonomia</a>, <a href="/books/n/gene/chac/">choreoacanthocytosis</a>, sensory neuropathy including <a href="/books/n/gene/hsn1/">hereditary sensory neuropathy type 1</a>, and several psychiatric conditions. Of these, only individuals with Lesch-Nyhan syndrome, Cornelia de Lange syndrome, and <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> dysautonomia regularly display loss of tissue as a result of the behavior. Finger and lip biting is so characteristic of Lesch-Nyhan syndrome that it is referred to as a behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>; in other syndromes associated with self-injury, the topography of behaviors is different, with head banging and/or nonspecific self-biting but not biting of the fingers and lips that results in tissue damage. Lesch-Nyhan syndrome should be strongly considered only when self-injurious behavior occurs in association with the full clinical picture of hyperuricemia and neurologic dysfunction.</p></div><div id="lns.Management"><h2 id="_lns_Management_">Management</h2><div id="lns.Evaluations_Following_Initial_Diagno"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with Lesch-Nyhan syndrome, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Complete blood count to evaluate for megaloblastic anemia</div></li><li class="half_rhythm"><div>Chemistry screen for uric acid concentration</div></li><li class="half_rhythm"><div>Neurologic examination</div></li><li class="half_rhythm"><div>Developmental/behavioral assessments</div></li><li class="half_rhythm"><div>Evaluation for renal calculi, usually by ultrasound examination of the abdomen</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="lns.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Hyperuricemia.</b> The overproduction of uric acid must be controlled to reduce the risk for nephrolithiasis, urate nephropathy, gouty arthritis, and tophi. Overproduction of uric acid can be controlled with allopurinol, which blocks the metabolism of hypoxanthine and xanthine into uric acid catalyzed by xanthine oxidase. The dose of allopurinol is adjusted to maintain the uric acid within normal limits.</p><p>Note: Control of serum concentration of uric acid from birth using allopurinol has no effect on behavioral and neurologic symptoms.</p><p>Allopurinol therapy results in the accumulation of hypoxanthine and xanthine; xanthine may also form stones. Therefore, care must be taken to avoid periods of relative dehydration that could concentrate the purine metabolites in the urinary system. Stones that develop in allopurinol-treated patients are usually composed of xanthine. A uric acid stone is an index of too little allopurinol. Hypoxanthine is soluble. Therefore, oxypurine analysis is useful in adjusting doses to maximize hypoxanthine. The allopurinol metabolite oxypurinol is also insoluble, and oxypurinol crystalluria has been observed with dehydration. Its concentration can also be monitored by oxypurine analysis of the urine.</p><p>Renal stones that form despite allopurinol may require lithotripsy or surgery.</p><p><b>Neurologic dysfunction.</b> Spasticity can be managed by the administration of baclofen or benzodiazepines.</p><p><b>Neurobehavioral symptoms.</b> Currently, no uniformly effective intervention for managing the neurobehavioral aspects of the disease exists. Self-injurious and other deleterious behaviors are best managed by a combination of physical, behavioral [<a class="bk_pop" href="#lns.REF.olson.2000.202">Olson &#x00026; Houlihan 2000</a>], psychiatric [<a class="bk_pop" href="#lns.REF.harris.2007">Harris 2007</a>], and medical interventions.</p><p>Because stress increases self-injury, behavioral management through aversive techniques (which reduce self-injury in other conditions) actually increases self-injury in individuals with Lesch-Nyhan syndrome. Virtually all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals require physical restraints to prevent self-injury and are restrained more than 75% of the time, often at their own request and sometimes with restraints that would appear to be ineffective as they do not physically prevent biting. Families report that affected individuals are at ease when restrained.</p><p>Sixty percent of individuals have their teeth extracted to avoid self-injury through biting. Families have found this to be an effective management technique. More conservative than tooth extraction are vital pulpotomy and coronal resection, which maintain the root portion of the tooth in the bone, an approach that may preserve alveolar bone [<a class="bk_pop" href="#lns.REF.lee.2002.66">Lee et al 2002</a>].</p><p>Behavioral extinction methods may be useful in a controlled setting for reducing self-injury, but seldom transfer well to the home setting [<a class="bk_pop" href="#lns.REF.harris.2007">Harris 2007</a>].</p></div><div id="lns.Prevention_of_Primary_Manifestations"><h3>Prevention of Primary Manifestations</h3><p>The overproduction of uric acid can be controlled with allopurinol, which blocks the metabolism of hypoxanthine and xanthine into uric acid.</p></div><div id="lns.Prevention_of_Secondary_Complication"><h3>Prevention of Secondary Complications</h3><p>Adjustment of the dose of allopurinol is required to minimize the complication of nephrolithiasis. Virtually any reduction of hyperuricemia will prevent urate nephropathy.</p></div><div id="lns.Surveillance"><h3>Surveillance</h3><p>Appropriate surveillance includes the following:</p><ul><li class="half_rhythm"><div>Monitor plasma uric acid concentration and urinary excretion of oxypurines.</div></li><li class="half_rhythm"><div>Review medical history for signs or symptoms of silent or active renal stones.</div></li><li class="half_rhythm"><div>Monitor <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals for early signs of self-injury.</div></li></ul></div><div id="lns.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Probenecid and other uricosuric drugs designed to reduce the serum concentration of uric acid are contraindicated because they augment the delivery of uric acid into the urinary system and raise the risk for acute anuria from deposition of uric acid crystals in the renal collecting system.</p><p>Periods of relative dehydration are to be avoided because they could concentrate the purine metabolites in the urinary system and increase the risk for renal stones or urate nephropathy with resulting oliguria/anuria.</p></div><div id="lns.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>Prenatal testing or testing of males at risk for Lesch-Nyhan syndrome immediately after birth enables prompt initiation of allopurinol therapy.</p><p>Some <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females develop gout in later years; thus, establishing carrier status of female relatives through genetic testing may be valuable to their clinical management.</p><p>See <a href="#lns.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="lns.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Elimination of self-injury and partial improvement of dystonia after deep brain stimulation in the globus pallidus was reported in a single patient [<a class="bk_pop" href="#lns.REF.taira.2003.414">Taira et al 2003</a>]. Of the small number of other individuals who have received this treatment, only one was successful; at least one died as a result of the procedure [Author, personal observation]. Deep brain stimulation must be considered experimental at present; evaluation of more <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals over longer periods is required to determine its effectiveness.</p><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions.</p></div><div id="lns.Other"><h3>Other</h3><p>Recent studies suggesting that gabapentin and carbamazepine may help attenuate self-injury and other behavioral disturbances have not been confirmed in a long-term study. Treatment with S-adenosylmethionine has led to mixed results [<a class="bk_pop" href="#lns.REF.dolcetta.2013.174">Dolcetta et al 2013</a>]. Treatment with intravenous AICAR was without effect on the behavior [<a class="bk_pop" href="#lns.REF.page.1995">Page et al 1995</a>].</p><p>No medication has been consistently effective in controlling the extrapyramidal motor features of the disease. The following have been unsuccessful in reducing neurologic or behavioral symptoms:</p><ul><li class="half_rhythm"><div>Partial exchange transfusion in two individuals</div></li><li class="half_rhythm"><div>Bone marrow transplantation (BMT). BMT in a mouse model of HPRT deficiency has had no effect on the neurologic manifestations [<a class="bk_pop" href="#lns.REF.wojcik.1999.57">Wojcik et al 1999</a>]. Bone marrow transplantation was also ineffective in humans [<a class="bk_pop" href="#lns.REF.nyhan.1986.113">Nyhan et al 1986</a>].</div></li></ul></div></div><div id="lns.Genetic_Counseling"><h2 id="_lns_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="lns.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Lesch-Nyhan syndrome is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/x-linked-recessive/">X-linked recessive</a> manner.</p></div><div id="lns.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The father of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male will not have the disease nor will he be a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> of the mutated <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a>.</div></li><li class="half_rhythm"><div>A woman who has an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> son and one other affected relative in the maternal line is an <a class="def" href="/books/n/gene/glossary/def-item/obligate-carrier/">obligate carrier</a>.</div></li><li class="half_rhythm"><div>If a woman has more than one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> son with an identified <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> which cannot be detected in her leukocyte DNA, she has <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li><li class="half_rhythm"><div>If a woman is the first in her family with an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> son, Haldane's rule predicts a 2/3 chance that she is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> and a 1/3 chance that the son has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/germline-variant/">germline variant</a>. <a class="bk_pop" href="#lns.REF.francke.1981">Francke et al [1981]</a> reported a higher ratio of carrier mothers.</div></li><li class="half_rhythm"><div>When an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male is the only affected individual in the family, several possibilities regarding his mother's <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status need to be considered:</div><ul><li class="half_rhythm"><div>The son has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>HPRT1</i> and his mother is not a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a>.</div></li><li class="half_rhythm"><div>His mother has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>HPRT1</i>, either as a <a class="def" href="/books/n/gene/glossary/def-item/germline-variant/">germline variant</a> (occurring at the time of her conception) or as <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> (occurring post-fertilization).</div></li><li class="half_rhythm"><div>His mother has a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> that she inherited from a maternal female ancestor.</div></li></ul></li><li class="half_rhythm"><div>Some <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females develop hyperuricemia.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of the mother.</div></li><li class="half_rhythm"><div>A female who is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> has a 50% chance of transmitting the <i>HPRT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in each pregnancy.</div><ul><li class="half_rhythm"><div>Sons who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> will be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</div></li><li class="half_rhythm"><div>Daughters who inherit the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> are carriers.</div></li><li class="half_rhythm"><div>Thus, with each pregnancy, a female who is a <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> has a 25% chance of having an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male, a 25% chance of having a carrier female, and a 50% chance of having a normal male or female.</div></li></ul></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> cannot be detected in the leukocyte DNA of the mother of the only <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> male in the family, the risk to sibs is low but greater than that of the general population because of the possibility of <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Males with Lesch-Nyhan syndrome do not reproduce. If a male with a less severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> reproduces, all of his daughters are obligate carriers and none of his sons is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Other family members.</b> The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s maternal aunts may be at risk of being carriers and the aunt's offspring, depending on their gender, may be at risk of being carriers or of being <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p></div><div id="lns.Carrier_Heterozygote_Detection"><h3>Carrier (Heterozygote) Detection</h3><p>Carrier testing of at-risk female relatives is possible if the <i>HPRT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> [<a class="bk_pop" href="#lns.REF.oneill.2004.51">O'Neill 2004</a>].</p></div><div id="lns.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#lns.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk, clarification of <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status, and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>, are carriers, or are at risk of being carriers.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="lns.Prenatal_Testing_and_Preimplantation"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Prenatal testing is possible for at-risk pregnancies [<a class="bk_pop" href="#lns.REF.nyhan.2003.807">Nyhan et al 2003</a>].</p><p><b>Molecular genetic testing.</b> Once the <i>HPRT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for Lesch-Nyhan syndrome are possible.</p><p><b>Biochemical genetic testing.</b> Assay of HPRT enzyme activity in cultured amniocytes or chorionic villus cells is the preferred method for prenatal testing if the <i>HPRT1</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has not been identified in the family. No false positive or false negative diagnoses have been encountered in prenatal testing but it is possible that maternal cells could contaminate and overgrow the culture.</p></div></div><div id="lns.Resources"><h2 id="_lns_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>International Lesch-Nyhan Disease Association</b></div><div>11402 Ferndale Street</div><div>Philadelphia PA 19116</div><div><b>Phone:</b> 215-677-4206</div></li><li class="half_rhythm"><div><b>Lesch-Nyhan Syndrome Children's Research Foundation</b></div><div>210 South Green Bay Road</div><div>Lake Forest IL 60045</div><div><b>Phone:</b> 847-234-3154</div><div><b>Fax:</b> 847-234-3136</div></li><li class="half_rhythm"><div><b>National Institute of Neurological Disorders and Stroke (NINDS)</b></div><div>PO Box 5801</div><div>Bethesda MD 20824</div><div><b>Phone:</b> 800-352-9424 (toll-free); 301-496-5751; 301-468-5981 (TTY)</div><div><a href="https://www.ninds.nih.gov/Disorders/All-Disorders/Lesch-Nyhan-Syndrome-Information-Page" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lesch-Nyhan Syndrome Information Page</a></div></li><li class="half_rhythm"><div><b>National Library of Medicine Genetics Home Reference</b></div><div><a href="http://ghr.nlm.nih.gov/condition=leschnyhansyndrome" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lesch-Nyhan syndrome</a></div></li><li class="half_rhythm"><div><b>NCBI Genes and Disease</b></div><div><a href="/books/NBK22194/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Lesch-Nyhan syndrome</a></div></li></ul></div><div id="lns.Molecular_Genetics"><h2 id="_lns_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="lns.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Lesch-Nyhan Syndrome: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1149/table/lns.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lns.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_lns.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_lns.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_lns.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_lns.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_lns.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_lns.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_lns.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/3251" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>HPRT1</i></a></td><td headers="hd_b_lns.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=3251" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Xq26<wbr style="display:inline-block"></wbr>​.2-q26.3</a></td><td headers="hd_b_lns.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P00492" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hypoxanthine-guanine phosphoribosyltransferase</a></td><td headers="hd_b_lns.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.ibiblio.org/dnam/mainpage.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Hypoxanthine Guanine Phosphoribosyltransferase 1; Lech-Nyhan Syndrome</a><br /><a href="http://databases.lovd.nl/shared/genes/HPRT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPRT1 database</a></td><td headers="hd_b_lns.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=HPRT1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPRT1</a></td><td headers="hd_b_lns.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=HPRT1[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HPRT1</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="lns.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="lns.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Lesch-Nyhan Syndrome (<a href="/omim/300322,308000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1149/table/lns.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__lns.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/300322" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">300322</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">LESCH-NYHAN SYNDROME; LNS</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/308000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">308000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE 1; HPRT1</td></tr></tbody></table></div></div><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> comprises nine exons over 43 kb of DNA and 657 nucleotides in the coding sequence. For a detailed summary of gene and protein information, see <a href="/books/NBK1149/#lns.molgen.TA">Table A</a>, <b>Gene</b>.</p><p><b>Benign variants.</b> No known benign variants exist in the <a class="def" href="/books/n/gene/glossary/def-item/coding-region/">coding region</a> of the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p><p><b>Pathogenic variants.</b> Pathogenic variants are spread nearly randomly throughout <i>HPRT1</i>. Each family generally has a unique <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> [<a class="bk_pop" href="#lns.REF.jinnah.2000.309">Jinnah et al 2000</a>]. Some pathogenic variants that have occurred independently in more than one family are known. In the 271 cases studied, 218 pathogenic DNA variants (primarily <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> and <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a> variants and small deletions/insertions) have been found [<a class="bk_pop" href="#lns.REF.jinnah.2000.309">Jinnah et al 2000</a>]. (For more information, see <a href="/books/NBK1149/#lns.molgen.TA">Table A</a>.)</p><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The HPRT enzyme (hypoxanthine-guanine phosphoribosyltransferase) catalyzes the conversion of hypoxanthine to IMP and guanine to GMP in the presence of phosphoribosylpyrophosphate. Thus, it recycles purines from DNA and RNA that are otherwise degraded. HPRT accounts for 0.05% of the total soluble protein in brain.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> The pathogenic variants result in nonfunctional or very low-function HPRT enzymatic activity.</p></div><div id="lns.References"><h2 id="_lns_References_">References</h2><div id="lns.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="lns.REF.bertelli.2004.767">Bertelli M, Randi D, Micheli V, Gallo S, Andrighetto G, Parmigiani P, Jacomelli G, Carella M, Lievore C, Pandolfo M. Molecular basis of hypoxanthine-guanine phosphoribosyltransferase deficiency in Italian Lesch-Nyhan patients: identification of nine novel mutations. <span><span class="ref-journal">J Inherit Metab Dis. </span>2004;<span class="ref-vol">27</span>:767–73.</span> [<a href="/pubmed/15505382" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15505382</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.de_gregorio.2005.70">De Gregorio L, Jinnah HA, Harris JC, Nyhan WL, Schretlen DJ, Trombley LM, O'Neill JP. Lesch-Nyhan disease in a female with a clinically normal monozygotic twin. <span><span class="ref-journal">Mol Genet Metab. </span>2005;<span class="ref-vol">85</span>:70–7.</span> [<a href="/pubmed/15862283" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15862283</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.de_gregorio.2000.263">De Gregorio L, Nyhan WL, Serafin E, Chamoles NA. An unexpected affected female patient in a classical Lesch-Nyhan family. <span><span class="ref-journal">Mol Genet Metab. </span>2000;<span class="ref-vol">69</span>:263–8.</span> [<a href="/pubmed/10767182" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10767182</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.dolcetta.2013.174">Dolcetta D, Parmigiani P, Salmaso L, Bernardelle R, Cesari U, Andrighetto G, Baschirotto G, Nyhan WL, Hladnik U. Quantitative evaluation of the clinical effects of S-Adenosylmethionine on mood and behavior in Lesch-Nyhan patients. <span><span class="ref-journal">Nucleosides Nucleotides Nucleic Acids. </span>2013;<span class="ref-vol">32</span>:174–88.</span> [<a href="/pubmed/24001191" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24001191</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.duan.2004.599">Duan J, Nilsson L, Lambert B. Structural and functional analysis of mutations at the human hypoxanthine phosphoribosyl transferase (HPRT1) locus. <span><span class="ref-journal">Hum Mutat. </span>2004;<span class="ref-vol">23</span>:599–611.</span> [<a href="/pubmed/15146465" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15146465</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.francke.1981">Francke U, Winter RM, Lin D, Bakay B, Seegmiller JE, Nyhan WL. Use of carrier detection tests to estimate male to female ratio of mutation rates in Lesch-Nyhan disease. In: Hook EB, Porter IH, eds. <em>Population Aspects of Human Mutation</em>. New York, NY: Academic Press. 1981:117-27.</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.fu.2014.1282">Fu R, Ceballos-Picot I, Torres RJ, Larovere LE, Yamada Y, Nguyen KV, Hegde M, Visser JE, Schretlen DJ, Nyhan WL, Puig JG, O'Neill PJ, Jinnah HA, et al.  Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. <span><span class="ref-journal">Brain. </span>2014;<span class="ref-vol">137</span>:1282–303.</span> [<a href="/pmc/articles/PMC3999711/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3999711</span></a>] [<a href="/pubmed/23975452" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23975452</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.harris.2007">Harris JC. Lesch Nyhan disease. In: Gilman S, ed. <em>MedLink Neurology</em>. San Diego, CA: MedLink Corporation. 2007.</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.harris.1998.547">Harris JC, Lee RR, Jinnah HA, Wong DF, Yaster M, Bryan RN. Craniocerebral magnetic resonance imaging measurement and findings in Lesch-Nyhan syndrome. <span><span class="ref-journal">Arch Neurol. </span>1998;<span class="ref-vol">55</span>:547–53.</span> [<a href="/pubmed/9561984" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9561984</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.hou.2006.1500">Hou JW. Atlantoaxial subluxation with recurrent consciousness disturbance in a boy with Lesch-Nyhan syndrome. <span><span class="ref-journal">Acta Paediatr. </span>2006;<span class="ref-vol">95</span>:1500–4.</span> [<a href="/pubmed/17062485" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17062485</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.jinnah.2000.309">Jinnah HA, De Gregorio L, Harris JC, Nyhan WL, O'Neill JP. The spectrum of inherited mutations causing HPRT deficiency: 75 new cases and a review of 196 previously reported cases. <span><span class="ref-journal">Mutat Res. </span>2000;<span class="ref-vol">463</span>:309–26.</span> [<a href="/pubmed/11018746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11018746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.jinnah.2004.1153">Jinnah HA, Harris JC, Nyhan WL, O'Neill JP. The spectrum of mutations causing HPRT deficiency: an update. <span><span class="ref-journal">Nucleosides Nucleotides Nucleic Acids. </span>2004;<span class="ref-vol">23</span>:1153–60.</span> [<a href="/pubmed/15571220" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15571220</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.jinnah.2010.671">Jinnah HA, Ceballos-Picot I, Torres RJ, Visser JE, Schretlen DJ, Verdu A, Lar&#x000f3;vere LE, Chen C-J, Cossu A, Wu Ch-H, Sampat R, Chang S-J, de Kremer RD, Nyhan W, Harris JC, Reich SG, Puig JG, et al.  Attenuated variants of Lesch-Nyhan disease. <span><span class="ref-journal">Brain. </span>2010;<span class="ref-vol">133</span>:671–89.</span> [<a href="/pmc/articles/PMC2842514/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2842514</span></a>] [<a href="/pubmed/20176575" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20176575</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.jinnah.2006.1201">Jinnah HA, Visser JE, Harris JC, Verdu A, Larovere L, Ceballos-Picot I, Gonzalez-Alegre P, Neychev V, Torres RJ, Dulac O, Desguerre I, Schretlen DJ, Robey KL, Barabas G, Bloem BR, Nyhan W, De Kremer R, Eddey GE, Puig JG, Reich SG. Delineation of the motor disorder of Lesch-Nyhan disease. <span><span class="ref-journal">Brain. </span>2006;<span class="ref-vol">129</span>:1201–17.</span> [<a href="/pmc/articles/PMC3508431/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3508431</span></a>] [<a href="/pubmed/16549399" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16549399</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.kassimatis.2005.447">Kassimatis TI, Simmonds HA, Goudas PC, Marinaki AM, Fairbanks LD, Diamandopoulos AA. HPRT deficiency as the cause of ESRD in a 24-year-old patient: a very rare presentation of the disorder. <span><span class="ref-journal">J Nephrol. </span>2005;<span class="ref-vol">18</span>:447–51.</span> [<a href="/pubmed/16245252" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16245252</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.lee.2002.66">Lee JH, Berkowitz RJ, Choi B. Oral self-mutilation in the Lesch-Nyhan syndrome. <span><span class="ref-journal">ASDC J Dent Child. </span>2002;<span class="ref-vol">69</span>:66–9.</span> [<a href="/pubmed/12119817" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12119817</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.lesch.1964.561">Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. <span><span class="ref-journal">Am J Med. </span>1964;<span class="ref-vol">36</span>:561–70.</span> [<a href="/pubmed/14142409" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14142409</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.neychev.2006.923">Neychev VK, Jinnah HA. Sudden death in Lesch-Nyhan disease. <span><span class="ref-journal">Dev Med Child Neurol. </span>2006;<span class="ref-vol">48</span>:923–6.</span> [<a href="/pmc/articles/PMC3507438/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3507438</span></a>] [<a href="/pubmed/17044962" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17044962</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.nyhan.2008.559">Nyhan WL. Lesch-Nyhan disease. <span><span class="ref-journal">Nucleosides Nucleotides Nucleic Acids. </span>2008;<span class="ref-vol">27</span>:559–63.</span> [<a href="/pubmed/18600504" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18600504</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.nyhan.2005">Nyhan WL, Barshop B, Ozand PT. Lesch-Nyhan disease. In: <em>Atlas of Metabolic Diseases</em>. 2 ed. London, UK: Hodder Arnold; 2005.</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.nyhan.1986.113">Nyhan WL, Page T, Gruber HE, Parkman R. Bone marrow transplantation in Lesch-Nyhan disease. <span><span class="ref-journal">Birth Defects Orig Artic Ser. </span>1986;<span class="ref-vol">22</span>:113–7.</span> [<a href="/pubmed/3516239" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3516239</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.nyhan.2003.807">Nyhan WL, Vuong LU, Broock R. Prenatal diagnosis of Lesch-Nyhan disease. <span><span class="ref-journal">Prenat Diagn. </span>2003;<span class="ref-vol">23</span>:807–9.</span> [<a href="/pubmed/14558024" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14558024</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.oneill.2004.51">O'Neill JP. Mutation carrier testing in Lesch-Nyhan syndrome families: HPRT mutant frequency and mutation analysis with peripheral blood T lymphocytes. <span><span class="ref-journal">Genet Test. </span>2004;<span class="ref-vol">8</span>:51–64.</span> [<a href="/pubmed/15140374" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15140374</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.olson.2000.202">Olson L, Houlihan D. A review of behavioral treatments used for Lesch-Nyhan syndrome. <span><span class="ref-journal">Behav Modif. </span>2000;<span class="ref-vol">24</span>:202–22.</span> [<a href="/pubmed/10804680" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10804680</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.page.1981.203">Page T, Bakay B, Nissinen E, Nyhan WL. Hypoxanthine-guanine phosphoribosyltransferase variants: correlation of clinical phenotype with enzyme activity. <span><span class="ref-journal">J Inherit Metab Dis. </span>1981;<span class="ref-vol">4</span>:203–6.</span> [<a href="/pubmed/6796771" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6796771</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.page.1995">Page T, Barshop B, Yu AL, Nyhan WL. Treatment of Lesch-Nyhan syndrome with AICAR. In: Sahota A, Taylor M, eds. <em>Purine and Pyrimidine Metabolism in Man</em>. Vol 8. New York, NY: Plenum Press; 1995:353-6.</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.page.1987.713">Page T, Nyhan WL, Morena de Vega V. Syndrome of mild mental retardation, spastic gait, and skeletal malformations in a family with partial deficiency of hypoxanthine-guanine phosphoribosyltransferase. <span><span class="ref-journal">Pediatrics. </span>1987;<span class="ref-vol">79</span>:713–7.</span> [<a href="/pubmed/3575027" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 3575027</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.puig.1998.950">Puig JG, Mateos FA, Torres RJ, Buno AS. Purine metabolism in female heterozygotes for hypoxanthine-guanine phosphoribosyltransferase deficiency. <span><span class="ref-journal">Eur J Clin Invest. </span>1998;<span class="ref-vol">28</span>:950–7.</span> [<a href="/pubmed/9824441" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9824441</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.puig.2001.102">Puig JG, Torres RJ, Mateos FA, Ramos TH, Arcas JM, Bu&#x000f1;o AS, O'Neill P. The spectrum of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Clinical experience based on 22 patients from 18 Spanish families. <span><span class="ref-journal">Medicine. </span>2001;<span class="ref-vol">80</span>:102.</span> [<a href="/pubmed/11307586" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11307586</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.rinat.2006.249">Rinat C, Zoref-Shani E, Ben-Neriah Z, Bromberg Y, Becker-Cohen R, Feinstein S, Sperling O, Frishberg Y. Molecular, biochemical, and genetic characterization of a female patient with Lesch-Nyhan disease. <span><span class="ref-journal">Mol Genet Metab. </span>2006;<span class="ref-vol">87</span>:249–52.</span> [<a href="/pubmed/16343967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16343967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.robey.2003.167">Robey KL, Reck JF, Giacomini KD, Barabas G, Eddey GE. Modes and patterns of self-mutilation in persons with Lesch-Nyhan disease. <span><span class="ref-journal">Dev Med Child Neurol. </span>2003;<span class="ref-vol">45</span>:167–71.</span> [<a href="/pubmed/12613772" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12613772</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.schretlen.2001.805">Schretlen DJ, Harris JC, Park KS, Jinnah HA, del Pozo NO. Neurocognitive functioning in Lesch-Nyhan disease and partial hypoxanthine-guanine phosphoribosyltransferase deficiency. <span><span class="ref-journal">J Int Neuropsychol Soc. </span>2001;<span class="ref-vol">7</span>:805–12.</span> [<a href="/pubmed/11771623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11771623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.schretlen.2005.673">Schretlen DJ, Ward J, Meyer SM, Yun J, Puig JG, Nyhan WL, Jinnah HA, Harris JC. Behavioral aspects of Lesch-Nyhan disease and its variants. <span><span class="ref-journal">Dev Med Child Neurol. </span>2005;<span class="ref-vol">47</span>:673–7.</span> [<a href="/pubmed/16174310" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16174310</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.seegmiller.1967.1682">Seegmiller JE, Rosenbloom FM, Kelley WN. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. <span><span class="ref-journal">Science. </span>1967;<span class="ref-vol">155</span>:1682–4.</span> [<a href="/pubmed/6020292" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 6020292</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.srivastava.2002.219">Srivastava T, O'Neill JP, Dasouki M, Simckes AM. Childhood hyperuricemia and acute renal failure resulting from a missense mutation in the HPRT gene. <span><span class="ref-journal">Am J Med Genet. </span>2002;<span class="ref-vol">108</span>:219–22.</span> [<a href="/pubmed/11891689" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11891689</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.taira.2003.414">Taira T, Kobayashi T, Hori T. Disappearance of self-mutilating behavior in a patient with lesch-nyhan syndrome after bilateral chronic stimulation of the globus pallidus internus. Case report. <span><span class="ref-journal">J Neurosurg. </span>2003;<span class="ref-vol">98</span>:414–6.</span> [<a href="/pubmed/12593632" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12593632</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="lns.REF.wojcik.1999.57">Wojcik BE, Jinnah HA, Muller-Sieburg CE, Friedmann T. Bone marrow transplantation does not ameliorate the neurologic symptoms in mice deficient in hypoxanthine guanine phosphoribosyl transferase (HPRT). <span><span class="ref-journal">Metab Brain Dis. </span>1999;<span class="ref-vol">14</span>:57–65.</span> [<a href="/pubmed/10348314" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 10348314</span></a>]</div></li></ul></div></div><div id="lns.Chapter_Notes"><h2 id="_lns_Chapter_Notes_">Chapter Notes</h2><div id="lns.Author_Notes"><h3>Author Notes</h3><p>Professor O'Neill is a molecular biologist who has studied <i>HPRT1</i> variants for 20 years. Since 1990, he has applied these methods to inherited <i>HPRT1</i> variants in order to define the variants involved in Lesch-Nyhan syndrome and related diseases. In particular, he applies these molecular methods to determine the <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> status of females in these families.</p><p>Dr Jinnah is a neurologist with more than ten years of experience in research and clinical management in Lesch-Nyhan syndrome. He has an NIH-funded laboratory program devoted to developing a better understanding of the abnormalities in brain function that lead to the neurobehavioral aspects of the disease.</p><p>Dr Harris is a developmental neuropsychiatrist who specializes in the treatment of psychiatric and behavioral problems in Lesch-Nyhan syndrome. His research focuses on neuroimaging studies in individuals with Lesch-Nyhan syndrome.</p><p>Dr Nyhan has devoted more than 55 years to research and patient care in genetic diseases of metabolism. He and Michael Lesch, MD, first described the Lesch-Nyhan syndrome in 1964. Clinical investigation of this disease and other disorders of purine metabolism are under study in an NIH-funded Clinical and Translational Research Institute at the UCSD Medical Center.</p></div><div id="lns.Author_History"><h3>Author History</h3><p>James C Harris, MD (2000-present) <br />Hyder A Jinnah, MD, PhD (2000-present) <br />Janice A Nicklas, PhD; University of Vermont (2000-2007) <br />William L Nyhan, MD, PhD (2000-present) <br />J Patrick O'Neill, PhD (2000-present)</p></div><div id="lns.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>15 May 2014 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>10 June 2010 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 January 2009 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> available clinically</div></li><li class="half_rhythm"><div>27 November 2007 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>8 February 2005 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>6 February 2003 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>25 September 2000 (me) Review posted live</div></li><li class="half_rhythm"><div>20 March 2000 (jn) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1149</span><span class="label">PMID: <a href="/pubmed/20301328" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301328</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/lenz/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/leukodys-ov/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1149&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1149/?report=reader">PubReader</a></li><li><a href="/books/NBK1149/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1149" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1149" style="display:none" title="Cite this Page"><div class="bk_tt">Nyhan WL, O'Neill JP, Jinnah HA, et al. Lesch-Nyhan Syndrome. 2000 Sep 25 [Updated 2014 May 15]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1149/pdf/Bookshelf_NBK1149.pdf">PDF version of this page</a> (433K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#lns.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#lns.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#lns.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#lns.Genetically_Related_Allelic_Disorder" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#lns.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#lns.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#lns.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#lns.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#lns.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#lns.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#lns.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=3251[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">HPRT1</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1488526" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1488526" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1488526" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1488526" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/18067674" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.</a><span class="source">[Orphanet J Rare Dis. 2007]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Hypoxanthine-guanine phosophoribosyltransferase (HPRT) deficiency: Lesch-Nyhan syndrome.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Torres RJ, Puig JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Orphanet J Rare Dis. 2007 Dec 8; 2:48. Epub 2007 Dec 8.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29879316" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedarticles&amp;logdbfrom=pubmed">GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.</a><span class="source">[Int J Rheum Dis. 2018]</span><div class="brieflinkpop offscreen_noflow">GLUT9 influences uric acid concentration in patients with Lesch-Nyhan disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Torres RJ, Puig JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Int J Rheum Dis. 2018 Jun; 21(6):1270-1276. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301734" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphoribosylpyrophosphate Synthetase Superactivity</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Phosphoribosylpyrophosphate Synthetase Superactivity<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">de Brouwer APM, Duley JA, Christodoulou J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/17697859" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.</a><span class="source">[Metabolism. 2007]</span><div class="brieflinkpop offscreen_noflow">Efficacy and safety of allopurinol in patients with hypoxanthine-guanine phosphoribosyltransferase deficiency.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Torres RJ, Prior C, Puig JG. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Metabolism. 2007 Sep; 56(9):1179-86. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/24930028" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.</a><span class="source">[Mol Genet Metab. 2014]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Genotypic and phenotypic spectrum in attenuated variants of Lesch-Nyhan disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Fu R, Chen CJ, Jinnah HA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Genet Metab. 2014 Aug; 112(4):280-5. Epub 2014 May 28.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301328" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301328" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041a4039a66ee2ba695572">Lesch-Nyhan Syndrome - GeneReviews®</a><div class="ralinkpop offscreen_noflow">Lesch-Nyhan Syndrome - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:26:08-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BDEA9E04084E10000000007A602BA&amp;ncbi_session=CE8BDEA9E041A401_1958SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1149%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1149&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1149/&amp;ncbi_pagename=Lesch-Nyhan Syndrome - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BDEA9E041A401_1958SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>